Maternal hair analysis for the detection of illicit drugs, medicines, and alcohol exposure during pregnancy

Therapeutic Drug Monitoring

Volumn 35, Issue 3, 2013, Pages 296-304

  Lendoiro, Elena ^a   González Colmenero, Eva ^b   Concheiro Guisán, Ana ^b   De Castro, Ana ^c   Cruz, Angelines ^a   López Rivadulla, Manuel ^a   Concheiro, Marta ^d  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^c Cienytech SL   (Spain)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Alcohol; Drugs of abuse; Hair; Pregnancy; Tobacco

Indexed keywords

ALCOHOL; AMPHETAMINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; COCAINE; DRONABINOL; ETHYL GLUCURONIDE; FENTANYL; HYPNOTIC AGENT; ILLICIT DRUG; KETAMINE; METHADONE; OPIATE; ZOPICLONE;

ALCOHOL ABUSE; ARTICLE; DRUG ABUSE; FEMALE; FIRST TRIMESTER PREGNANCY; HAIR ANALYSIS; HUMAN; INTERVIEW; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LOW BIRTH WEIGHT; MATERNAL SMOKING; NEWBORN; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; STATISTICAL ANALYSIS; STUDENT T TEST; TANDEM MASS SPECTROMETRY; THIRD TRIMESTER PREGNANCY; TOBACCO; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; ALCOHOL DRINKING; ALCOHOL-RELATED DISORDERS; CHROMATOGRAPHY, LIQUID; FEMALE; HAIR; HUMANS; INFANT, NEWBORN; INTERVIEW, PSYCHOLOGICAL; LIMIT OF DETECTION; MIDDLE AGED; NEONATAL ABSTINENCE SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; SMOKING; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84880075838     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e318288453f     Document Type: Article

References (38)

1. Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-44, HHS Publication No. (SMA) 12-4713. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2012.
2. European Monitoring Center for Drugs and Drug Addiction, Annual Report 2011. Available at: http://www.emcdda.europa.eu/attachements.cfm/att-143743-EN- EMCDDA-AR2011-EN.pdf. Accessed October 2, 2012.
3. Plan Nacional sobre Drogas, Programa de Encuestas Domiciliarias sobre Alcohol y Drogas en España 2009. Available at: http://www.pnsd.msc.es/ Categoria2/observa/pdf/EDADES-2009.pdf. Accessed November 4, 2012.
4. Pichini S, Puig C, Zuccaro P, et al. Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the "Meconium Project". Forensic Sci Int. 2005;153:59-65. (Pubitemid 41008653)
5. Sherwood RA, Keating J, Kavvadia V, et al. Substance misuse in early pregnancy and relationship to fetal outcome. Eur J Pediatr. 1999;158: 488-492. (Pubitemid 29240803)
6. Friguls B, Joya X, Garcia J, et al. Assessment of exposure to drugs of abuse during pregnancy by hair analysis in a Mediterranean island. Addiction. 2012;107:1471-1479.
7. Joya X, Gomez-Culebras M, Callejón A, et al. Cocaine use during pregnancy assessed by hair analysis in a Canary Islands cohort. BMC Pregnancy Childbirth. 2012;12:2.
8. Falcon M, Valero F, Pellegrini M, et al. Exposure to psychoactive substances in women who request voluntary termination of pregnancy assessed by serum and hair testing. Forensic Sci Int. 2010;196:22-26.
9. Keegan J, Parva M, Finnegan M, et al. Addiction in pregnancy. J Addict Dis. 2010;2:175-191.
10. Shankaran S, Lester BM, Das A, et al. Impact of maternal substance use during pregnancy on childhood outcome. Semin Fetal Neonatal Med. 2007;12:143-150. (Pubitemid 46366882)
11. Farst KJ, Valentine JL, Whit Hall R. Drug testing for newborn exposure to illicit substances in pregnancy: pitfalls and pearls. Int J Pediatr. 2011; 2011:951616.
12. Finnegan LP, Kaltenbach K. Neonatal abstinence syndrome. In: Hoekelman RA, Friedman SB, Nelson NM, et al, eds. Primary Pediatric Care. St Louis, MO: Mosby Year Book; 1992:1367-1378.
13. Gray T, Huestis M. Bioanalytical procedures for monitoring in utero drug exposure. Anal Bioanal Chem. 2007;388:1455-1465. (Pubitemid 47150872)
14. Lozano J, Garcia-Algar O, Vall O, et al. Biological matrices for the evaluation of in utero exposure to drugs of abuse. Ther Drug Monit. 2007;29:711-734. (Pubitemid 350190848)
15. Morini L, Marchei E, Pellegrini M, et al. Liquid chromatography with tandem mass spectrometric detection for the measurement of ethyl glucuronide and ethyl sulfate in meconium: new biomarkers of gestational ethanol exposure? Ther Drug Monit. 2008;30:725-732.
16. de Castro A, Concheiro M, Shakleya DM, et al. Simultaneous quantification of methadone, cocaine, opiates, and metabolites in human placenta by liquid chromatography-mass spectrometry. J Anal Toxicol. 2009;33: 243-252.
17. Shakleya DM, Dams R, Choo RE, et al. Simultaneous liquid chromatographymass spectrometry quantification of urinary opiates, cocaine, and metabolites in opiate-dependent pregnant women in methadone-maintenance treatment. J Anal Toxicol. 2010;34:17-25.
18. Gallardo E, Queiroz JA. The role of alternative specimens in toxicological analysis. Biomed Chromatogr. 2008;22:795-821.
19. Bar-Oz B, Klein J, Karaskov T, et al. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch Dis Child Fetal Neonatal Ed. 2003;88:F98-F100. (Pubitemid 36269528)
20. Ostrea EM Jr., Knapp DK, Tannenbaum L, et al. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatr. 2001;138:344-348. (Pubitemid 32207135)
21. Garcia-Bournissen F, Rokach B, Karaskov T, et al. Cocaine detection in maternal and neonatal hair: implications to fetal toxicology. Ther Drug Monit. 2007;29:71-76. (Pubitemid 46279879)
22. Vinner E, Vignau J, Thibault D, et al. Hair analysis of opiates in mothers and newborns for evaluating opiate exposure during pregnancy. Forensic Sci Int. 2003;133:57-62. (Pubitemid 36555421)
23. Moller M, Karaskov T, Koren G. Opioid detection in maternal and neonatal hair and meconium: characterization of an at-risk population and implications to fetal toxicology. Ther Drug Monit. 2010;32:318-323.
24. Garcia-Bournissen F, Rokach B, Karaskov T, et al. Methamphetamine detection in maternal and neonatal hair: implications for fetal safety. Arch Dis Child Fetal Neonatal Ed. 2007;92:351-355.
25. Lendoiro E, Quintela O, de Castro A, et al. Target screening and confirmation of 35 licit and illicit drugs and metabolites in hair by LC-MSMS. Forensic Sci Int. 2012;217:207-215.
26. Cooper GA, Kronstrand R, Kintz P. Society of Hair Testing guidelines for drug testing in hair. Forensic Sci Int. 2012;218:20-24.
27. Society of Hair Testing. Use of Alcohol Markers in Hair for Abstinence Assessment. 2012. Available at: http://soht.org/pdf/Use%20of%20Alcohol %20Markers%20in%20Hair%20for%20Abstinence%20Assessment% 202012.pdf. Accessed November 4, 2012.
28. Society of Hair Testing. Consensus of the Society of Hair Testing on Hair Testing for Chronic Excessive Alcohol Consumption. 2011. Available at: http://soht.org/pdf/Revised%20Alcohol%20marker%20Consensus.pdf. Accessed November 4, 2012.
29. Pragst F. Interpretation problems in a forensic case of abstinence determination using alcohol markers in hair. Forensic Sci Int. 2012;217: e4-e7.
30. Kulaga V, Shor S, Koren G. Correlation between drugs of abuse and alcohol by hair analysis: parents at risk for having children with fetal alcohol spectrum disorder. Alcohol. 2010;44:615-621.
31. Kintz P. Bioanalytical procedures for detection of chemical agents in hair in the case of drug-facilitated crimes. Anal Bioanal Chem. 2007;388: 1467-1474. (Pubitemid 47150873)
32. Jaakkola JJK, Jaakkola N, Zahlsen K. Fetal growth and length of gestation in relation to prenatal exposure to environmental tobacco smoke assessed by hair nicotine concentration. Environ Health Perspect. 2001;109:557-561. (Pubitemid 32998765)
33. Pichini S, Garcia-Algar O, Muñoz L, et al. Assessment of chronic exposure to cigarette smoke and its change during pregnancy by segmental analysis of maternal hair nicotine. J Expo Sci Environ Epidemiol. 2003;13: 144-151. (Pubitemid 36566144)
34. Ness RB, Grisso JA, Hirschinger N, et al. Cocaine and tobacco use and the risk of spontaneous abortion. N Engl J Med. 1999;340:333-339. (Pubitemid 29090797)
35. Walsh RA. Effects of maternal smoking on adverse pregnancy outcomes: examination of the criteria of causation. Hum Biol. 1994;66: 1059-1092.
36. Vik T, Vatten L, Markestad T, et al. Morbidity during the first year of life in small for gestational age infants. Arch Dis Child Fetal Neonatal Ed. 1996;75:F33-F37.
37. English DR, Hulse GK, Milne E, et al. Maternal cannabis use and birth weight: a meta-Analysis. Addiction. 1997;92:1553-1560. (Pubitemid 27499566)
38. Gibson GT, Baghurst PA, Colley DP. Maternal alcohol, tobacco and cannabis consumption and the outcome of pregnancy. Aust N Z J Obstet Gynaecol. 1983;23:15-19. (Pubitemid 13143997)